Multi‑modal longevity protocol integrating lifestyle, supplements, and autologous pro‑regenerative cell‑conditioned media (pilot)
بروتوكول متعدد لتحسين طول العمر يشمل نمط حياة ومكملات ووسط خلوي متجدد ذاتي (تجريبي)
Journal: Frontiers in aging
University: PubMed
Study Type: clinical trial
Evidence Level: low
Participants: 16
Published:
⚠️ Warning: This is a preliminary study (animal/cell) and has not been proven in humans.
30-Second Summary
This single‑arm, open‑label pilot (16 enrolled, 14 completers) tested a 17‑week program combining lifestyle optimization, targeted supplements, and two IV infusions of autologous pro‑regenerative cell‑conditioned media. Small but statistically significant reductions in PhenoAge (~2.0 years) and an epigenetic age clock (~2.7 years) were reported, with heterogeneous responses and lower baseline serum iron predicting larger epigenetic age declines; no adverse events were reported, but the small uncontrolled design limits causal inference.